Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009
Posted by: DrugsNews on: 23 Nov, 2009
- In: Drugs News| News
- Comment!
Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009
- LX1031 represents a first-in-class compound for IBS -
Inhibitor of tryptophan hydroxylase, a key enzyme in serotonin
production – First demonstration of new mechanism of action in
treatment of IBS Presentation summary will be available…
Read more about Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009
| Indian Pharmacy! Looking for Generic Medications? Quality Drugs at affordable prices! Reliable Indian Pharmacy www.IndianPharmacy.org |
#1 Canadian Pharmacy Online! The Lowest Prices from Canadian Drugstore! Various payments, secure shopping, worldwide shipping! www.CanadianPharmacyLtd.org |
What are the Drugs-Review websites?
The Drugs-Review websites are NOT but will be your number one stop for all the latest news, comment and pharmaceutical industry information.
Related posts:
- Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel Syndrome
- Tioga Pharmaceuticals, Inc. Raises $18 Million To Fund Phase 3 Clinical Trial In Irritable Bowel Syndrome
- A Survey Into The Current Situation Of Britain’s Irritable Bowel Syndrome
